Absci is trading at $7.30 (+5.80%) following a strong market open, though no company-specific announcements were released to explain the move.
- The stock is likely benefiting from a broader risk-on environment, with the Nasdaq Composite up 2.35% following strong Microsoft earnings and cooler inflation data.
- Biotech and growth-oriented names are catching a bid as market sentiment improves across the sector.
- Given recent volatility, the move may reflect momentum and broader market trends rather than a fresh company-specific catalyst.